Artykuły w czasopismach na temat „Inc National Cargo Bureau”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Inc National Cargo Bureau”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Lebwohl, M., A. Deodhar, S. Schwartzman, C. Salvarani, M. Feely, D. Zhu, P. Rahman i in. "AB1105 LONG-TERM SAFETY OF IXEKIZUMAB TREATMENT IN ADULT PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS, OR AXIAL SPONDYLOARTHRITIS: A POST-HOC ANALYSIS OF END-OF-STUDY PROGRAM DATA RELATING TO MAJOR ADVERSE CARDIOVASCULAR EVENTS". Annals of the Rheumatic Diseases 82, Suppl 1 (30.05.2023): 1780–81. http://dx.doi.org/10.1136/annrheumdis-2023-eular.3412.
Pełny tekst źródłaMatsui, T., N. Sugiyama, S. Toyoizumi, F. Matsuyama, T. Murata, Y. Urata, K. Kawahata i S. Tohma. "POS0286 INCIDENCE OF MALIGNANCIES IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM A LARGE JAPANESE NATIONAL REGISTRY". Annals of the Rheumatic Diseases 80, Suppl 1 (19.05.2021): 368–69. http://dx.doi.org/10.1136/annrheumdis-2021-eular.365.
Pełny tekst źródłaBishop, Ryan T., Tao Li, Raghunandan R. Alugubelli, Oliver Hampton, Ariosto Siqueira Silva, Steven Grant, Kenneth H. Shain i Conor C. Lynch. "Acid Ceramidase (ASAH1) Mediates Intrinsic and Intercellular Transfer of Proteasome Inhibitor Resistance in Multiple Myeloma". Blood 138, Supplement 1 (5.11.2021): 1206. http://dx.doi.org/10.1182/blood-2021-152686.
Pełny tekst źródłaKhuat, Lam T., Catherine T. Le, Chien-Chun Pai, Robin Shields-Cutler, Shernan Holtan, Armin Rashidi, Sarah Parker i in. "Obesity-Induced Microbiome Alterations Result in Severe Gastrointestinal Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation". Blood 134, Supplement_1 (13.11.2019): 1922. http://dx.doi.org/10.1182/blood-2019-127743.
Pełny tekst źródłaYijun, Liao, Li Ping i Huang Wenjing. "Research on the Impact of GNI on Express Delivery Volume in China". Journal of Economics and Public Finance 6, nr 3 (12.08.2020): p110. http://dx.doi.org/10.22158/jepf.v6n3p110.
Pełny tekst źródłaNakazaki, Kumi, Toshiaki Takezaki, Yosuke Masamoto, Yasushi Miyazaki, Kinuko Mitani i Mineo Kurokawa. "A Nationwide Survey of Lower Risk Myelodysplastic Syndromes in Japan". Blood 138, Supplement 1 (5.11.2021): 4662. http://dx.doi.org/10.1182/blood-2021-146093.
Pełny tekst źródłaDiugwu, Ikechukwu A., Obioma R. Nwaogbe, Victor Omoke, Solomon T. Johnson i Ashem E. Egila. "Assessment of operational performance of public sector funded infrastructure in Nigeria: the airports perspective". Independent Journal of Management & Production 10, nr 1 (1.02.2019): 133. http://dx.doi.org/10.14807/ijmp.v10i1.828.
Pełny tekst źródłaOjutalayo, John Folayan, Ndikom Obed Boniface, Nnadi Kenneth Ugwu, Akujuobi Aghaegbulam Bonaventure Chidiebere i Theophilus Chinonyerem Nwokedi. "Poverty, Youth Unemployment, Maritime Piracy, and Sea Robbery in Nigeria between 1995 and 2013: A Relationship Assessment". Maritime Technology and Research 5, nr 4 (13.07.2023): 265349. http://dx.doi.org/10.33175/mtr.2023.265349.
Pełny tekst źródłaRubnitz, Jeffrey E., Thomas B. Alexander, Theodore W. Laetsch, Seong Lin Khaw, Vinod A. Pullarkat, Joseph T. Opferman, Kathryn G. Roberts i in. "Venetoclax and Navitoclax in Pediatric Patients with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma". Blood 136, Supplement 1 (5.11.2020): 12–13. http://dx.doi.org/10.1182/blood-2020-134582.
Pełny tekst źródłaCasulo, Carla, Michelle Byrtek, Keith L. Dawson, Xiaolei Zhou, Christopher R. Flowers, Charles M. Farber, John D. Hainsworth, James R. Cerhan, Brian K. Link i Jonathan W. Friedberg. "Disease Characteristics, Treatment Patterns, and Outcomes of Follicular Lymphoma in Patients 40 Years of Age and Younger: An Analysis from the National LymphoCare Study". Blood 124, nr 21 (6.12.2014): 3044. http://dx.doi.org/10.1182/blood.v124.21.3044.3044.
Pełny tekst źródłaLee, Seung Tae, Antonio Pinto, Habte Yimer, Don Stevens, Wanda Knopinska Posluszny, Merrill Kingman Shum, Sudhir Manda i in. "A Phase 2/3, Multicenter Randomized Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) with or without Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR DLBCL)". Blood 138, Supplement 1 (5.11.2021): 1420. http://dx.doi.org/10.1182/blood-2021-150025.
Pełny tekst źródłaJourneycake, Janna M., Cedric Hermans, Jonathan M. Ducore, Miguel A. Escobar, Guy Young, Michael Wang, Doris Quon i in. "Single 225μg/Kg Dose Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Rapid Hemostasis in Joint Bleeds for Persons with Hemophilia Α or Β with Inhibitors: A PERSEPT1 Subset Analysis". Blood 136, Supplement 1 (5.11.2020): 2–3. http://dx.doi.org/10.1182/blood-2020-136443.
Pełny tekst źródłaConnelly, K., R. Kandane-Rathnayake, V. Golder, W. Louthrenoo, Y. H. Chen, J. Cho, A. Lateef i in. "POS1481 INFORMING TRIAL MEASUREMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS: FREQUENCY OF DOMAIN-SPECIFIC DISEASE ACTIVITY IN A MULTI-NATIONAL OBSERVATIONAL COHORT". Annals of the Rheumatic Diseases 82, Suppl 1 (30.05.2023): 1095.2–1096. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2885.
Pełny tekst źródłaSavage, Kerry J., Steven M. Horwitz, Ranjana H. Advani, Jacob H. Christensen, Eva Domingo-Domenech, Giuseppe Rossi, Franck Morschhauser i in. "An Exploratory Analysis of Brentuximab Vedotin Plus CHP (A+CHP) in the Frontline Treatment of Patients with CD30+ Peripheral T-Cell Lymphomas (ECHELON-2): Impact of Consolidative Stem Cell Transplant". Blood 134, Supplement_1 (13.11.2019): 464. http://dx.doi.org/10.1182/blood-2019-122781.
Pełny tekst źródłaZinzani, Pier Luigi, Felipe Samaniego, Wojciech Jurczak, Nilanjan Ghosh, Enrico Derenzini, James A. Reeves, Wanda Knopinska-Posluszny i in. "Umbralisib, the Once Daily Dual Inhibitor of PI3Kδ and Casein Kinase-1ε Demonstrates Clinical Activity in Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: Results from the Phase 2 Global Unity-NHL Trial". Blood 136, Supplement 1 (5.11.2020): 34–35. http://dx.doi.org/10.1182/blood-2020-134851.
Pełny tekst źródłaPipe, Steven W., Michael Recht, Nigel S. Key, Frank W. G. Leebeek, Giancarlo Castaman, Susan U. Lattimore, Paul Van Der Valk i in. "First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies". Blood 136, Supplement_2 (19.11.2020): LBA—6—LBA—6. http://dx.doi.org/10.1182/blood-2020-143560.
Pełny tekst źródłaKwak, Larry W., Juan Manuel Sancho, Seok-Goo Cho, Hideyuki Nakazawa, Junji Suzumiya, Gayane Tumyan, Jin Seok Kim i in. "Long-Term Efficacy and Safety (27 months) of the Biosimilar CT-P10 in Patients with Low Tumor Burden Follicular Lymphoma". Blood 136, Supplement 1 (5.11.2020): 27–28. http://dx.doi.org/10.1182/blood-2020-135999.
Pełny tekst źródłaEscobar, Miguel A., Doris Quon, Cindy A. Leissinger, James V. Luck, Ahmad Al-Sabbagh, Daniel Bonzo, Ian S. Mitchell, W. Allan Alexander i Cedric Hermans. "PERSEPT3: A Phase 3 Clinical Trial to Evaluate the Hemostatic Efficacy of Eptacog Beta (Recombinant Human FVIIa) in Perioperative Care in Subjects with Hemophilia Α or B with Inhibitors". Blood 136, Supplement 1 (5.11.2020): 34–36. http://dx.doi.org/10.1182/blood-2020-136448.
Pełny tekst źródłaMatsuda, Kensuke, Taisuke Jo, Masashi Miyauchi, Kazuhiro Toyama, Kumi Nakazaki, Hideo Yasunaga i Mineo Kurokawa. "Primary Prophylaxis with Pegfilgrastim in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Nation-Wide, Propensity Score Based Analysis". Blood 134, Supplement_1 (13.11.2019): 1605. http://dx.doi.org/10.1182/blood-2019-123611.
Pełny tekst źródłaLee, Hun Ju, Michael Choi, Tanya Siddiqi, Jacqueline Barrientos, William G. Wierda, Iris Isufi, Joseph Tuscano i in. "Phase 1b/2 Study of Cirmtuzumab and Ibrutinib in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL)". Blood 138, Supplement 1 (5.11.2021): 3534. http://dx.doi.org/10.1182/blood-2021-148779.
Pełny tekst źródłaMcGraw, Kathy L., Chia-Ho Cheng, Y. Ann Chen, Hsin-An Hou, Guilio Genovese, Thomas Cluzeau, Andrea Pellagatti i in. "SNP-Array Genome Wide Association Study Meta-Analysis Identifies Innate Immune Susceptibility Loci Associated with Non-Del(5q) Myelodysplastic Syndromes Predisposition". Blood 132, Supplement 1 (29.11.2018): 107. http://dx.doi.org/10.1182/blood-2018-99-118747.
Pełny tekst źródłaWolach, Ofir, Itai Levi, Jonathan Canaani, Tamar Tadmor, Sigal Tavor, Ilana Hellmann, Tsila Zuckerman i in. "First Results from a Nationwide Prospective Non-Interventional Study of Venetoclax-Based 1st Line Therapies in Patients with Acute Myeloid Leukemia (AML) - Revive Study". Blood 136, Supplement 1 (5.11.2020): 27–28. http://dx.doi.org/10.1182/blood-2020-139923.
Pełny tekst źródłaKernder, A., H. Morf, P. Klemm, D. Vossen, M. Meyer, I. Haase, J. Mucke i in. "POS1458-HPR DIGITAL RHEUMATOLOGY IN THE ERA OF COVID-19: RESULTS OF A NATIONAL PATIENT AND PHYSICIAN SURVEY". Annals of the Rheumatic Diseases 80, Suppl 1 (19.05.2021): 1013–14. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1328.
Pełny tekst źródłaGhia, Paolo, John N. Allan, Tanya Siddiqi, Thomas J. Kipps, Bryone J. Kuss, Stephen Opat, Ian W. Flinn i in. "First-Line Treatment with Ibrutinib (Ibr) Plus Venetoclax (Ven) for Chronic Lymphocytic Leukemia (CLL): 2-Year Post-Randomization Disease-Free Survival (DFS) Results from the Minimal Residual Disease (MRD) Cohort of the Phase 2 Captivate Study". Blood 138, Supplement 1 (5.11.2021): 68. http://dx.doi.org/10.1182/blood-2021-144544.
Pełny tekst źródłaGribben, John G., Wojciech Jurczak, Ryan W. Jacobs, Sebastian Grosicki, Krzysztof Giannopoulos, Tomasz Wrobel, Syed F. Zafar i in. "Umbralisib Plus Ublituximab (U2) Is Superior to Obinutuzumab Plus Chlorambucil (O+Chl) in Patients with Treatment Naïve (TN) and Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from the Phase 3 Unity-CLL Study". Blood 136, Supplement 1 (5.11.2020): 37–39. http://dx.doi.org/10.1182/blood-2020-134783.
Pełny tekst źródłaSchiller, Gary J., Laura Finn, Gail J. Roboz, Johnnie J. Orozco, Tiffany Lin, Mary M. Chen i Mohamed M. Hegazi. "Early Clinical Evaluation of Potential Synergy of Targeted Radiotherapy with Lintuzumab-Ac225 and Venetoclax in Relapsed/Refractory AML". Blood 138, Supplement 1 (5.11.2021): 3412. http://dx.doi.org/10.1182/blood-2021-146018.
Pełny tekst źródłaCostello, Caitlin L., Tara K. Gregory, Syed Abbas Ali, Jesus G. Berdeja, Krina K. Patel, Nina D. Shah, Eric Ostertag i in. "Phase 2 Study of the Response and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME)". Blood 134, Supplement_1 (13.11.2019): 3184. http://dx.doi.org/10.1182/blood-2019-129562.
Pełny tekst źródłaRollison, Dana E., Kenneth H. Shain, Ji-Hyun Lee, Shalaka S. Hampras, William Fulp, Kate Fisher, Najla H. Al Ali i in. "Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients". Blood 124, nr 21 (6.12.2014): 1912. http://dx.doi.org/10.1182/blood.v124.21.1912.1912.
Pełny tekst źródłaContributors. "ACKNOWLEDGMENTS". Acta Medica Philippina 54, nr 6 (26.12.2020). http://dx.doi.org/10.47895/amp.v54i6.2626.
Pełny tekst źródłaKANIA, MICHAL, BEATA KON, KONRAD M. KAMINSKI, JERZY HOHENDORFF, TOMASZ KLUPA, PRZEMYSLAW W. WITEK i MACIEJ MALECKI. "1841-PUB: Diabetes as a Risk Factor of Death in Hospitalized COVID-19 Patients—An Analysis of a National Hospitalization Database from Poland, 2020". Diabetes 72, Supplement_1 (23.06.2023). http://dx.doi.org/10.2337/db23-1841-pub.
Pełny tekst źródłaLEELARATHNA, LALANTHA, CHRIS J. SUTTON, MARK EVANS, SANKALPA NEUPANE, GERRY RAYMAN, SARAH LUMLEY, IAIN C. CRANSTON i in. "951-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Subgroup Analysis from the FLASH-UK Study". Diabetes 72, Supplement_1 (20.06.2023). http://dx.doi.org/10.2337/db23-951-p.
Pełny tekst źródłaFORLENZA, GREGORY P., SARAH A. MACLEISH, DOROTHY I. SHULMAN, BENJAMIN U. NWOSU, SIHAM ACCACHA, SATISH K. GARG, ANDERS L. CARLSON i in. "1901-LB: Safety and Glycemic Outcomes Using the MiniMed 780G System with a Disposable All-in-One Sensor with Transmitter". Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-1901-lb.
Pełny tekst źródłaMAGLIANO, DIANNA J., LEI CHEN, JEDIDIAH I. MORTON, AGUS SALIM, BENDIX CARSTENSEN, EDWARD W. GREGG, MEDA E. PAVKOV i in. "1380-P: A Multicountry Analysis of Trends in Incidence of Young-Onset Type 2 Diabetes". Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-1380-p.
Pełny tekst źródłaCHEPP, VALERIE, STEVEN P. MASIANO, ALEX MILINOVICH, JACQUELINE FOX, KEVIN M. PANTALONE i ANITA D. MISRA-HEBERT. "1125-P: Provider Experience Caring for Elderly Patients with Uncontrolled Type 2 Diabetes and Hospitalization". Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-1125-p.
Pełny tekst źródłaOjutalayo, John Folamyan, Ndikom Obed Boniface, Nnadi Kenneth Ugwu i Theophilus Chinonyerem Nwokedi. "Study on the Effects of Maritime Piracy and Sea Robbery on Economic Growth in Nigeria". International Journal of Social Science and Research 1, nr 1 (6.09.2023). http://dx.doi.org/10.58531/ijssr/1/1/2.
Pełny tekst źródłaVIGERSKY, ROBERT A., BRUCE W. BODE, RONALD L. BRAZG, BRUCE A. BUCKINGHAM, ANDERS L. CARLSON, KEVIN B. KAISERMAN, MARK KIPNES i in. "100-LB: Glycemic Control Using Recommended Settings in Youth and Adults with Type 1 Diabetes (T1D) —Minimed 780G System with the Calibration-Free Guardian 4 Sensor Results". Diabetes 71, Supplement_1 (1.06.2022). http://dx.doi.org/10.2337/db22-100-lb.
Pełny tekst źródłaBARNARD, KATHARINE, VICKY P. TAXIARCHI, MARK EVANS, SANKALPA NEUPANE, GERRY RAYMAN, SARAH LUMLEY, IAIN C. CRANSTON i in. "633-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Psychosocial Outcomes from the FLASH-UK Study". Diabetes 72, Supplement_1 (20.06.2023). http://dx.doi.org/10.2337/db23-633-p.
Pełny tekst źródłaMI KANG, YU, GIORGIO E. M. MELLONI, AVIVIT CAHN, ITAMAR RAZ, FILIPE MOURA, DEEPAK L. BHATT, SILVIO E. INZUCCHI i in. "1895-LB: Fasting C-Peptide and Type 1 Diabetes Polygenic Score Predict Diabetic Ketoacidosis in People with Type 2 Diabetes in DECLARE-TIMI 58". Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-1895-lb.
Pełny tekst źródłaMI KANG, YU, GIORGIO E. M. MELLONI, AVIVIT CAHN, ITAMAR RAZ, FILIPE MOURA, DEEPAK L. BHATT, SILVIO E. INZUCCHI i in. "1896-LB: Clinical Features and C-Peptide Levels Associated with Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Dapagliflozin vs. Placebo—Insights from DECLARE-TIMI 58". Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-1896-lb.
Pełny tekst źródłaWEINSTOCK, RUTH S., ZACHARY THOMPSON, RICHARD M. BERGENSTAL, TERRA L. CUSHMAN, ROBIN L. GAL, CRAIG KOLLMAN, DAVIDA F. KRUGER i in. "263-OR: Older Adults Benefit from Virtual Support for CGM Use but Require Longer Visits". Diabetes 72, Supplement_1 (20.06.2023). http://dx.doi.org/10.2337/db23-263-or.
Pełny tekst źródłaMASIANO, STEVEN P., LARISA G. TERESHCHENKO, VALERIE CHEPP, ALEX MILINOVICH, JACQUELINE FOX, KEVIN M. PANTALONE i ANITA D. MISRA-HEBERT. "1111-P: Predictors of Type 2 Diabetes (T2D) Medication Change and Improved A1C among Older Adults Post-hospitalization". Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-1111-p.
Pełny tekst źródłaMILLER, KELLEE, HUYEN NGUYEN, JENNIFER L. SHERR, YOGISH C. KUDVA, ANDERS L. CARLSON, NAOMI CHAYTOR, DANIEL DESALVO i in. "265-OR: Understanding Patterns of GLP-1/GLP-1 RA Use among Individuals with Type 1 Diabetes—A T1D Exchange (T1DX) Online Registry Analysis". Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-265-or.
Pełny tekst źródłaBODE, BRUCE W., TIMOTHY S. BAILEY, KRISTIN N. CASTORINO, MARK P. CHRISTIANSEN, SATISH K. GARG, KEVIN B. KAISERMAN, DAVID R. LILJENQUIST i in. "672-P: Performance of a New Disposable Zero-Calibration Continuous Glucose Monitoring (CGM) Sensor". Diabetes 71, Supplement_1 (1.06.2022). http://dx.doi.org/10.2337/db22-672-p.
Pełny tekst źródłaFAULDS, EILEEN R., YASAMAN BADAKHSHI, ANDREW BOUTSICARIS, MATTHEW C. EXLINE, JOI HESTER, LAUREEN G. JONES, MOLLY MCNETT i in. "230-OR: Hybrid Continuous Glucose Monitoring Protocols in the Intensive Care Unit—Multicenter Experience". Diabetes 72, Supplement_1 (20.06.2023). http://dx.doi.org/10.2337/db23-230-or.
Pełny tekst źródłaEBERT, THOMAS, NOSHEEN SATTAR, MARNI GREIG, CLAUDIA LAMINA, MARC FROISSART, KAI-UWE ECKARDT, JÜRGEN FLOEGE i in. "808-P: Association between Analogue Compared with Human Insulin and the Outcomes of Mortality, Hospitalization, MACE, and Hypoglycemia in Hemodialysis Patients with Type 2 Diabetes: The ARO Research Initiative". Diabetes 71, Supplement_1 (1.06.2022). http://dx.doi.org/10.2337/db22-808-p.
Pełny tekst źródłaDUBSKY, MICHAL, ROBERT ROLAND, NATÁLIA MARHEFKOVÁ, PETER WOHLFAHRT, PETER NOVODVORSKY, VLADIMIR KARMAZIN, MARTIN HALUZIK i MICHAL PAZDERNIK. "185-OR: The Role of Optical Coherent Tomography in the Estimation of Cardiovascular Risk in Asymptomatic Patients with Type 1 Diabetes". Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-185-or.
Pełny tekst źródłaDESHMUKH, HARSHAL, BEATRICE PIERI, EMMA G. WILMOT, PRATIK CHOUDHARY, NAJEEB SHAH, VASILEIOS TSATLIDIS, ALISTAIR N. LUMB, ROBERT E. RYDER, CHRISTOPHER WALTON i THOZHUKAT SATHYAPALAN. "90-OR: FreeStyle Libre (FSL) Time in Range (TIR) and Time Below Range (TBR) : Impact on HbA1c, Diabetes-Related Distress (DRD) , and Resource Utilisation in the Association of British Clinical Diabetologists (ABCD) National Audit". Diabetes 71, Supplement_1 (1.06.2022). http://dx.doi.org/10.2337/db22-90-or.
Pełny tekst źródłaFORLENZA, GREGORY P., BRUCE W. BODE, ANDERS L. CARLSON, AMY B. CRIEGO, SUE A. BROWN, RUTH S. WEINSTOCK, DAVID W. HANSEN i in. "766-P: Glycemic Outcomes with the Omnipod 5 Automated Insulin Delivery (AID) System Stratified by Baseline Hypoglycemia Risk among People with Type 1 Diabetes (T1D) Ages 2 to 70 Years". Diabetes 71, Supplement_1 (1.06.2022). http://dx.doi.org/10.2337/db22-766-p.
Pełny tekst źródłaSCHOELWER, MELISSA, BRUCE W. BODE, ANDERS L. CARLSON, AMY B. CRIEGO, GREGORY P. FORLENZA, RUTH S. WEINSTOCK, DAVID W. HANSEN i in. "765-P: Glycemic Outcomes across Total Daily Insulin Doses with the Omnipod 5 Automated Insulin Delivery System (AID) among People with Type 1 Diabetes (T1D) Ages 2 to 70 Years". Diabetes 71, Supplement_1 (1.06.2022). http://dx.doi.org/10.2337/db22-765-p.
Pełny tekst źródłaHOOD, KOREY K., RICHARD M. BERGENSTAL, TERRA L. CUSHMAN, ROBIN L. GAL, CRAIG KOLLMAN, DAVIDA F. KRUGER, MARY L. JOHNSON i in. "1031-P: Virtual Clinic Support—Patient-Reported Outcome Benefits". Diabetes 72, Supplement_1 (20.06.2023). http://dx.doi.org/10.2337/db23-1031-p.
Pełny tekst źródła